Search - tctmd.com

Displaying 341 - 360 of 8219

Sort: Relevancy | Date

Presentation TCT 2016

GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous Coronary Intervention in Patients with STEMI with and without Preceding Fibrinolytic Therapy

Presenter: Thomas F. Luscher, Patrick W. Serruys, Francisco Fdez-Aviles

October 31, 2016

Presentation TCT 2016

Kuwait Responds: How Would I Have Treated This Case in My Cath Lab?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari, Khaled Almerri

October 31, 2016

Presentation TCT 2016

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Presenter: Thomas F. Luscher, Patrick W. Serruys, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Li Zhi

October 31, 2016

Presentation TCT 2016

TCT 66: Effects of Dual Antiplatelet Therapy Cessation Among Patients With Diabetes Mellitus After PCI With DES

Presenter: Sorin J. Brener, Jean-François Tanguay, Michela Faggioni

October 31, 2016

Presentation TCT 2016

Introduction and Session Objectives

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari

October 31, 2016

Presentation TCT 2016

DISRUPT CAD: A multicenter, prospective, single-arm study of percutaneous lithoplasty prior to stent implantation in heavily calcified coronary lesions

Presenter: Joseph A. Hill, Steven P. Marso, Todd J. Brinton

October 31, 2016

Presentation TCT 2016

A Single Center Study Evaluating the Long-Term Durability of Self-Expanding Transcatheter Heart Valves After Treatment of Severe Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Erik W. Holy

October 31, 2016

Presentation TCT 2016

TCT 48: Medical Therapy and Clinical Outcomes With Spontaneous Coronary Artery Dissection

Presenter: Javier Escaned, Christoph K. Naber, Jaya Chandrasekhar

October 31, 2016

Presentation TCT 2016

TCT 40: One-Year Outcome of a Multicenter Clinical Study Evaluating a Novel Self-Expanding and Resheathable Transcatheter Aortic Valve System

Presenter: Lutz Buellesfeld, Raj Makkar, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

TCT 32: Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and Four-Year Clinical and Imaging Results

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Presentation TCT 2016

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

Presenter: Joseph A. Hill, Steven P. Marso, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Henrique B. Ribeiro

October 31, 2016

Presentation TCT 2016

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo

October 31, 2016

Presentation TCT 2016

PERFECT: A Prospective Registry Evaluating the Effects of Pan-Pelvic Endovascular Intervention on Erectile Function and Lower Urinary Tract Symptoms

Presenter: Joseph A. Hill, Steven P. Marso, Tzung-Dau Wang

October 31, 2016

Presentation TCT 2016

YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy

Presenter: Spencer B. King III, Jagat Narula, Annapoorna Kini

October 31, 2016

Presentation TCT 2016

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth

October 31, 2016

Presentation TCT 2016

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Michael Haude

October 31, 2016

Advertisement

GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous Coronary Intervention in Patients with STEMI with and without Preceding Fibrinolytic Therapy

Kuwait Responds: How Would I Have Treated This Case in My Cath Lab?

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

TCT 66: Effects of Dual Antiplatelet Therapy Cessation Among Patients With Diabetes Mellitus After PCI With DES

Introduction and Session Objectives

DISRUPT CAD: A multicenter, prospective, single-arm study of percutaneous lithoplasty prior to stent implantation in heavily calcified coronary lesions

A Single Center Study Evaluating the Long-Term Durability of Self-Expanding Transcatheter Heart Valves After Treatment of Severe Aortic Stenosis

TCT 48: Medical Therapy and Clinical Outcomes With Spontaneous Coronary Artery Dissection

TCT 40: One-Year Outcome of a Multicenter Clinical Study Evaluating a Novel Self-Expanding and Resheathable Transcatheter Aortic Valve System

TCT 32: Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and Four-Year Clinical and Imaging Results

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

PERFECT: A Prospective Registry Evaluating the Effects of Pan-Pelvic Endovascular Intervention on Erectile Function and Lower Urinary Tract Symptoms

YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content